MagVenture receives CE approvals for noninvasive brain treatment of addiction, OCD, and depression with anxiety symptoms ...Middle East

PR Newswire - News
MagVenture receives CE approvals for noninvasive brain treatment of addiction, OCD, and depression with anxiety symptoms
COPENHAGEN, Denmark, April 28, 2021 /PRNewswire/ -- Global MedTech pioneer MagVenture has received CE approval for the treatment of addiction and Obsessive-Compulsive Disorder (OCD). In addition, MagVenture TMS Therapy® can reduce the symptoms of comorbid anxiety in patients suffering...

Hence then, the article about magventure receives ce approvals for noninvasive brain treatment of addiction ocd and depression with anxiety symptoms was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( MagVenture receives CE approvals for noninvasive brain treatment of addiction, OCD, and depression with anxiety symptoms )

Apple Storegoogle play

Last updated :

Also on site :